Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015

Abstract

HR+ breast cancer is increasing in incidence among premenopausal women, and HR+ high-grade cancer was associated with reduced survival among women aged 20-29 years. Our findings can help guide further evaluation of preventive, diagnostic, and therapeutic strategies for breast cancer among premenopausal women.